Centralization of ovarian cancer surgery: Do patients benefit?

European Journal of Gynaecological Oncology

Volumn 31, Issue 4, 2010, Pages 429-433

  Ghaemmaghami, F ^a,d   Hassanzadeh, M ^b   Karimi Zarchi, M ^c   Modari Gilani, M ^a   Behtash, N ^a   Mousavi, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytoreductive surgery; Disease free survival; Ovarian cancer; Overall survival; Prognosis of ovarian cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CENTRALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; GYNECOLOGY; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IRAN; MAJOR CLINICAL STUDY; MALIGMANT OVARIAN GERM CELL TUMOR; OVARY CARCINOMA; OVARY TUMOR; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SEX CORD TUMOR; TREATMENT RESPONSE; ADOLESCENT; CANCER STAGING; CHILD; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PATHOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77956108443     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. th ed. St. Louis, Mosby, 2002, 289.
2. National Cancer Institute of Canada, Statistics Canada, provincial/Territorial Cancer Registries, Health Canada. Canadian Cancer Statistics, 1998, 13 (abstract).
3. Parkin D.M., Whelan S.L., Ferlay J.., Teppo L., Thomsa D.B. (eds.). Cancer incidence in five continents vol. VIII. In: IARC Scientific publ. no. 155. Lyon, France: International Agency for Research on Cancer, 2002.
4. Ioka A., Tsukuma H., Ajiki, W., Oshima A.: "Ovarian cancer incidence and survival by histologic type in Osaka, Japan". Cancer Sci, 2003, 94, 292.
5. Kumpulainen S., Grenman S., Kyyronen P., Pukkala E., Sankila R.: "Evidence of benefit from centralized treatment of ovarian cancer: A nation wide population based survival analysis in finland". Int. J. Cancer, 2002, 102, 541.
6. Rosen L., Stasik J.J., Reed J.F., Olenwine J.A., Aronof J.S., Sherman D.: "Variations in colon and rectal surgical mortality. Comparison of specialities with a state-legislated database". Dis. Colon Rectum, 1996, 39, 129.
7. Bokey E.L., Chapuis P.H., Dent O.F., Newland R.C., Koorey S.G., Zelas P.J., Stewart P. et al.: "Factors affecting survival after excision of the rectum for cancer: a multivariate analysis". Dis. Colon Rectum., 1997, 40, 3.
8. Gillis C.R., Hole D.J.: "Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland". BMJ, 1996, 312, 145.
9. Eisenkop S.M., Spirtos N.M., Montag T.W., Nalick R.H., Wang H.J.: "The impact of subspecially training on the management of advanced ovarian cancer". Gynecol. Oncol., 1992, 47, 203.
10. Trimble E.L., Kosari C.A., Cornelison T.L., Christian M.C.: "Improved survival for women with ovarian cancer". Gynecol. Oncol., 1999, 72, 458.
11. Griffiths C.T.: "Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma". Natl cancer Inst. Monogr., 1975, 47, 101.
12. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., Karlan B.Y.: "Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer". Gynecol. Oncol., 1999, 72, 278.
13. Hoskins W.J., Bundy B.N., Thigpen J.T., Omura G.A.: "The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: a gynecologic oncology gloup study". Gynecol. Oncol., 1992, 47, 159.
14. Hoskins W.J.: "Surgical staging and cytoreductive surgery of epithelial ovarian cancer". Cancer, 1993, 71, 1534.
15. Le T., Adolph A., Krepart G.V., Lotocki R., Heywood M.S.: "The benefits of comprehensive surgical staging in the management of early-stage of epithelial ovarian carcinoma". Gynecol. Oncol., 2002, 85, 351.
16. Junor E.J., Hole D.J., McNulty L., Mason M., Young J.: "Specialist gynecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients". Br. J. Obstet. Gynecol., 1999, 106, 1130.
17. Eisenkop S.M., Friedman R.L., Wang H.J.: "Complete cytoreductive surgery in feasivle and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study". Gynecol. Oncol., 1998, 69, 103.
18. Nguyen H.N., Averate H.E., Hoskins W., Penalver M., Sevin B., Steren A.: "National survey of ovarian carcinoma. Part V: the impact of physicians specialty on patients survival". Cancer, 1993, 72, 3663.
19. Bertelsen K.: "Tumor reduction surgery and longterm survival in advanced ovarian cancer: a DACOVA study". Gynecol. Oncol., 1990, 38, 203.
20. Accounts Commission for Scotland. Fighting the silent killer: optimizing ovarian cancer management in Scotland. Edinburgh, the Commission, 1998.
21. A Framework for commissioning cancer services. A Joint working Group Response by the Royal college of obstetricians and Gynaecologists and the British Gynaecological cancer society. London, RCOG press, January 1997.
22. Steinberg K.K., Smith S.J., Stroup D.F., Olkin I., Lee N.C., Williamson G.D., Thacker S.B.: "Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies". Am. J. Epidemiol., 1997, 145, 917.
23. Dexeus S., Labastida R., Dexeus D.: "Conservative management of epithelial ovarian cancer (review). Eur. J. Gynaecol. Oncol., 2005, 26, 473.
24. Lang J.H.: "Lymph node metastasis in Stage I ovarian carcinoma". Chin. Med. J., 1994, 107, 643.
25. Eisenkop S.M., Spirtos N.M., Lin W.C.: "'Optimal' cytoreduction for advanced epithelial ovarian cancer: a commentary". Gynecol. Oncol., 2006, 103, 329.
26. Tingulstad S., Jeldestad F.E., Hangen B.: "The effect of center alization of primary surgery on survival in ovarian cancer patient". Obstet. Gynecol., 2003, 102, 499.
27. Kehoe S., Powell J., Wilson S., Woodman C.: "The influence of the operating surgeons specialization on patient survival in ovarian carcinoma". Br. J Cancer, 1994, 70, 1014.
28. Olaitan A., Weeks J., Mocroff A., Smith J., Howe K., Murdoch J.: "The surgical management of women with ovarian cancer in the south west of England". Br. J Cancer, 2001, 85, 1824.
29. Elit L., Bondy S.J., Paszat L., Przybysz R., Levine M.: "Outcome in surgery for ovarian cancer". Gynecol. Oncol., 2002, 87, 260.
30. Munstedt K., von Georgi R., Misselwitz B., Zygmunt M., Stillger R., Kunzel W. et al.: "Centralizing surgery for gynecologic oncology - a strategy assuring better quality treatment". Gynecol. Oncol., 2003, 89, 4.
31. th ed. Philadelphia, Lippincott Williams & Wilkins, 2004.